MedPath
HSA Approval

BISACODYL TABLET 5 mg

SIN03615P

BISACODYL TABLET 5 mg

BISACODYL TABLET 5 mg

July 15, 1989

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

ENTERIC COATED TABLET

ORAL

Medical Information

A06AB02

bisacodyl

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

Bisacodyl

5 mg

Bisacodyl

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BISACODYL TABLET 5 mg - HSA Approval | MedPath